X28F3VA
Division Aortic Valve to New Technology Group 10 with Intraluminal Bioprosthetic Valve Leaflet Splitting Technology in Existing Valve, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | 8 Division |
| Body Part | F Aortic Valve |
| Approach | 3 Percutaneous |
| Device | V Intraluminal Bioprosthetic Valve Leaflet Splitting Technology in Existing Valve |
| Qualifier | A New Technology Group 10 |
Operation Definition
Cutting into a body part, without draining fluids and/or gases from the body part, in order to separate or transect a body part
Procedure Overview
This family involves cutting into a cardiovascular structure using an emerging technology in order to separate or transect part of it, without draining fluid or gas, distinguishing it from procedures aimed at destroying tissue with energy alone. Clinically, this kind of intervention is used to interrupt an abnormal structure or aberrant pathway within the heart or vessels, such as isolating tissue that is contributing to an arrhythmia or a structural abnormality, when a newly approved cutting technology offers a more precise or less invasive way to do so than existing surgical tools.
Because it is grouped under New Technology, the defining feature isn't simply that tissue was divided, but that a specific, recently approved device or energy delivery system was used to accomplish that division.
Anatomy & Axis Detail
Aortic Valve
The aortic valve separates the left ventricle from the aorta and is a common target when a diseased native or previously implanted valve threatens to obstruct a coronary ostium during transcatheter valve replacement. Division here refers to intentionally cutting a leaflet, most often with an electrified guidewire advanced across the valve, to split the leaflet lengthwise so it splays open rather than pinning against the aortic wall and blocking coronary flow once a new valve frame is deployed. The maneuver does not remove tissue and does not restore normal valve competence on its own; it is a preparatory step performed immediately before or during valve replacement, typically documented alongside the primary implantation procedure and guided by fluoroscopy and echocardiography to confirm leaflet position.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Intraluminal Bioprosthetic Valve Leaflet Splitting Technology in Existing Valve
This value represents technology used to split the leaflets of an already-implanted bioprosthetic valve before a second transcatheter valve is placed inside it, most commonly to prevent coronary artery obstruction during valve-in-valve procedures. It is distinct from primary valve replacement devices because it modifies existing prosthetic material rather than introducing a new valve. The technique is closely related to, but coded separately from, the radiofrequency leaflet laceration approach.
Qualifier: New Technology Group 10
New Technology Group 10 flags a procedure as part of the 2023 batch of add-on codes recognized under the New Technology section. The value itself carries no information about the device or drug involved; that comes from the table, body part, and approach values alongside it. Coders should not confuse it with Group 9 or Group 11, which cover the cohorts approved in the years immediately before and after.
Coding & Documentation
Coders need documentation naming the specific new-technology device or cutting method along with the exact cardiovascular structure transected, since this determines whether the New Technology code value applies versus a standard Division code. A common pitfall is coding this as a Destruction procedure when the physician's note describes ablation of tissue with heat or cold rather than an actual physical transection, or missing the qualifying technology detail entirely and defaulting to a Medical and Surgical division code.
Commonly Confused With
This family is most often confused with Destruction procedures like cardiac ablation, which eliminate tissue with energy rather than cutting through it, and with standard Division codes that describe the same anatomic action without the qualifying new technology. Reviewing whether the note describes physical transection versus energy-based tissue destruction is the key differentiator.